Concepedia

Author

Andrea S. Porpiglia

University of Tennessee Health Science Center

Also Known As

Andrea Porpiglia, Andrea S Porpiglia, Andrea S. Porpiglia, Porpiglia A

50

Publications

396

Citations

10

H-Index

21

Concepts

All Affiliations

University of Tennessee Health Science CenterFox Chase Cancer CenterSt. Jude Children's Research HospitalDuke Cancer InstituteThe University of Texas Southwestern Medical Center
AS

About

Andrea S. Porpiglia is an author at University of Tennessee Health Science Center specializing in cancer research, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

102

2

Education

1

1

82

3

Nursing

1

1

82

4

Public Health

1

1

20

5

Counseling

1

1

82

Andrea S. Porpiglia

×

8

Publications

294

Citations

8

H-Index

YearCitations

NCCN Guidelines® Insights: Survivorship, Version 1.2023

Tara Sanft, Andrew T. Day, Shannon Ansbaugh,

Journal of the National Comprehensive Cancer Network

2023

82

Clinical and molecular analysis of patients with defects in μ heavy chain gene

Eduardo López Granados, Andrea S. Porpiglia, Mary Beth Hogan,

Journal of Clinical Investigation

2002

63

Clinical and molecular analysis of patients with defects in μ heavy chain gene

Eduardo López Granados, Andrea S. Porpiglia, Mary Beth Hogan,

Journal of Clinical Investigation

2002

60

NCCN Guidelines® Insights: Survivorship, Version 1.2022

Tara Sanft, Andrew T. Day, Lindsay L. Peterson,

Journal of the National Comprehensive Cancer Network

2022

28

A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA

Christopher G. Verdone, Jennifer A. Bayron, Cecilia Chang,

Breast Cancer Research and Treatment

2022

20

NCCN Guidelines® Insights: Survivorship, Version 2.2024

Tara Sanft, Andrew T. Day, Mindy Goldman,

Journal of the National Comprehensive Cancer Network

2024

17

Should patients with hormone receptor–positive, HER2–negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Austin D. Williams, Karen Ruth, Saba Shaikh,

Cancer

2023

14

NCCN Guidelines® Insights: Survivorship, Version 2.2025

Tara Sanft, Andrew T. Day, Shannon M. Ansbaugh,

Journal of the National Comprehensive Cancer Network

2025

10

Page 1